GAM
ALDR

Gemmer Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Gemmer Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-125
Closed -$1K – 1303
2017
Q2 		$1K Hold
125
– – ﹤0.01% 1232
2017
Q1 		$3K Buy
+125
New +$2.77K ﹤0.01% 1151
2016
Q4 		– Sell
-125
Closed -$4K – 1267
2016
Q3 		$4K Hold
125
– – ﹤0.01% 1001
2016
Q2 		$3K Hold
125
– – ﹤0.01% 1120
2016
Q1 		$3K Hold
125
– – ﹤0.01% 1013
2015
Q4 		$4K Hold
125
– – ﹤0.01% 942
2015
Q3 		$4K Hold
125
– – ﹤0.01% 927
2015
Q2 		$7K Buy
+125
New +$4.55K ﹤0.01% 739

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return